Full access
Clinical & Research News
Published Online: 2 February 2007

One Psychotropic On Medicaid List Of Most Given Drugs

Mark MoranAuthors Info & Affiliations
Publication: Psychiatric News
Volume 42, Number 3
https://doi.org/10.1176/pn.42.3.0029b
Haloperidol decanoate (50 mg) was among the top 20 physician-administered drugs in the Medicaid program, in terms of dollar volume.
The antipsychotic ranked 17th in a list of physician-administered“ multiple-source” drugs, according to the federal Centers for Medicare and Medicaid Services (CMS). multiple-source drugs are those marketed by more than one manufacturer.
Haloperidol was the only psychiatric drug on the list. The top three drugs on the list are Paclitaxel, Carboplatin, and Ceftriaxone sodium.
The list was compiled using 2004-2005 national data extracted from the Medicaid Statistical Information System. This system includes data on national medication codes and names, as well as other information that can be shared with state officials involved with Medicaid programs.
The information was compiled by the Department of Health and Human services, the parent agency of cms, in an effort to encourage the states to collect manufacturer rebates they are due for certain physician-administered drugs as part of the 1990 Medicaid Drug Rebate Program.
In the past, the Office of the Inspector General had found that most state Medicaid programs were failing to collect the medication rebates they were entitled to receive.
Effective January 1 state Medicaid programs are required by the Deficit Reduction act of 2005 (DRA) to collect national drug codes for the 20 multiple-source physician-administered drugs with the highest dollar volume in the Medicaid program. Further, beginning January 1, 2008, the DRA requires that the states that do not collect codes on these 20 frequently used drugs will not receive federal matching payments for the drugs unless they receive a hardship waiver.
The medication list is posted at<www.cms.hhs.gov/DeficitReductionAct/40_PhysicianAdministeredDrugs.asp>.▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 42 • Number 3 • February 2, 2007
Pages: 29

History

Published online: 2 February 2007
Published in print: February 2, 2007

Authors

Affiliations

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.